Australia's Althea jumps on cannabis product approval in Ireland

Peak Processing

20/05/2022 03:55

** Shares of cannabis-based pharma co Althea Group  AGH.AX 
jump as much as 4.2% to A$0.125, post their biggest intraday pct
gain since May 13 
    ** AGH says the Irish medicines regulator, Health Products
Regulatory Authority, has approved a cannabis product for
prescription and supply in the country  urn:newsml:reuters.com:*:nASX26MZz2
    ** Adds it has submitted applications for other products as
well for consideration by the Irish health regulator
    ** Stock down 46.7% this year, as of last close

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))